Navigation Links
Early predictive model may be new 'weapon' against leading cause of death on battlefield
Date:10/24/2007

CHICAGO (October 24, 2007) -- Combat physicians in war-torn areas like Iraq and Afghanistan may be able to accurately predict which casualties require massive blood transfusions (MT), and thereby increase a soldier's chances of survival, according to research published in the October issue of The Journal of the American College of Surgeons. The study found that the presence of a combination of three variables -- assessed immediately upon arrival at the combat support hospital -- is highly predictive of which soldiers will need MT, thus allowing physicians to mobilize the necessary resources to transfuse large amounts of blood. The three variables are hemoglobin 11g/dL, International Normalized Ratio > 1.5, and a penetrating injury mechanism such as those caused by improvised explosive devices (IEDs) or high-powered weapons.

Hemorrhage (blood loss) is the leading cause of death on the battlefield. Severely injured patients require MT to restore adequate delivery of oxygen to the body. "The sooner we know that a solider needs a massive blood transfusion, the better," said Martin A. Schreiber, MD, FACS, chief of trauma at Oregon Health & Science University, Portland. "Since we have limited access to blood products in combat hospitals and we rely heavily on walking blood banks, it is crucial to be able to mobilize these precious resources early after patients are injured."

Identifying donors and then testing their blood for viruses like hepatitis C and HIV can take up to one hour, a critical period of time in a severely injured patient.

This retrospective cohort analysis included 558 combat victims treated at two combat support hospitals in Iraq. Patients who required MT (n=247), defined as delivery of 10 units of a combination of stored red blood cells and fresh whole blood in the first 24 hours after injury, were compared with patients who did not (n=311). Potentially predictive variables studied were age, gender, mechanism of injury, International Normalized Ratio (INR, the ratio of a patient's prothrombin time to a normal, or control, sample that is used to determine the blood's tendency to clot), prothrombin time, partial thromboplastin time, hemoglobin level and platelet count.

Based on a stepwise logistic regression analysis, a hemoglobin level 11 grams/deciliter (g/dL), INR >1.5 and a penetrating injury mechanism (e.g., injuries resulting from improvised explosive devices (IEDs) and high-powered weapons), were found to be independently predictive of the need for MT. The single most predictive variable was a hemoglobin level 11 g/dL, with an odds ratio of 7.7. Researchers determined that a combination of these three variables reliably predicts the need for MT.

Dr. Schreiber added that this work is a unique addition to the literature on predictors of MT because the study population consisted primarily of young male patients with injuries sustained by IEDs and high-powered weapons, which is quite different from a typical civilian population. Despite these facts, mortality in the MT group was identical to the mortality reported by a recently published study from a large civilian center.

Researchers also found that coagulopathy (a defect in the body's blood clotting process) occurs early after injury in severely injured combat victims and is associated with the need for MT and high mortality. Mortality was 39 percent in the MT group and 1 percent in the non-MT group (p<0.001).

The primary finding of this study is that the combination of hemoglobin 11 g/dL, INR > 1.5, and a penetrating mechanism reliably predict the need for MT. Using rapid laboratory technology, these variables are available within a few minutes of the patients' arrival, allowing the treating physicians to organize the resources necessary to deal with an MT patient. Dr. Schreiber is a Lieutenant Colonel in the Unites States Army Reserve.


'/>"/>

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
Weber Shandwick Worldwide
Source:Eurekalert

Related medicine news :

1. Gene linked to early puberty in girls
2. Cancer drugs in development nearly doubled since 1995
3. Nearly all asthma deaths preventable
4. Ductal lavage may detect early breast cancer
5. Doctors advice early anemia tests
6. Heart disease threat starts early in life for Diabetics
7. Early detection of prostate cancer
8. Early detection of heart attack
9. Early puberty linked to nutrition
10. Exercise to Prevent Early Breast Cancer
11. Drug Found To Bring Relief For Individuals With Early Parkinson’
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... ... Dr. Robert Mondavi, one of the dentists in Torrance , is now ... as more patients are discovering the many different ways they can change and improve ... to them and which ones might work for their smiles. , “One of ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored ... satisfaction survey, earning them second place for Tampa’s Best Places to Work. They were ... “This is a great accomplishment for our team,” says RMS Human Resources Manager Irene ...
(Date:4/29/2016)... Newport Beach, CA (PRWEB) , ... April 29, 2016 , ... ... Dr. Jane L. Frederick, Dr. Sanaz Ghazal, and Dr. Daniel A. Potter -- are ... the Society for Assisted Reproductive Technology (SART). In April, SART published the ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... Tie-up with Government hospitals as ... to save newborns   Fortis La Femme, ... collaboration with Breast Milk Foundation (BMF), a non-profit organization within ... Bank, ,Amaara, in Delhi-NCR today. This non-profit centre recognizes that ... and should be available to babies deprived of mother,s milk.  ...
(Date:4/27/2016)... April 27, 2016 Oasmia ... developer of a new generation of drugs within ... survival results for Paclical/Apealea in the Phase III ... with epithelial ovarian cancer. These preliminary results showed ... combination with carboplatin versus Taxol in combination with ...
(Date:4/26/2016)... , April 26, 2016 Diplomat Pharmacy, ... of Jennifer Hagerman , Pharm D., to Vice ... growing role at Diplomat, Hagerman will continue to lead ... company that delivers custom education and training to Diplomat ... specialty pharmacy industry. Diplomat University also houses the quality ...
Breaking Medicine Technology: